Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/2/2025

Significance of Lymph Node Evaluation in Breast Cancer Management

Lymph Node Evaluation and Staging

  • The National Comprehensive Cancer Network recommends that at least 10 lymph nodes should be provided for pathologic evaluation to accurately stage the axilla 1
  • The number of positive lymph nodes is a critical factor in determining breast cancer staging according to the TNM system (pN1 if 1-3 lymph nodes, pN2 if 4-9 lymph nodes, and pN3 if ≥10 lymph nodes are involved) 3

Radiation Therapy Recommendations Based on Lymph Node Status

  • The National Comprehensive Cancer Network recommends that patients with 4 or more positive lymph nodes should receive postmastectomy radiation therapy to the chest wall and regional lymph nodes (category 1 recommendation) 2, 4, 5
  • For patients who undergo lumpectomy with 4 or more positive nodes, the National Comprehensive Cancer Network recommends radiation therapy to whole breast with or without boost, plus regional nodal irradiation (category 1) 4, 5, 6
  • Three randomized clinical trials have shown that disease-free and overall survival advantages are conferred by irradiation of the chest wall and regional lymph nodes in women with 4 or more positive axillary lymph nodes 1, 7
  • For patients with 1-3 positive lymph nodes after lumpectomy, the National Comprehensive Cancer Network recommends radiation therapy to whole breast with or without boost (category 1); strongly consider regional nodal irradiation based on risk estimate 4, 5, 6

Regional Nodal Irradiation Details

  • Regional nodal irradiation includes treatment of the supraclavicular area, infraclavicular region, internal mammary nodes, and any part of the axillary bed considered at risk 4, 5
  • The MA.20 and EORTC 22922 trials demonstrated that after 10 years of median follow-up, regional nodal irradiation improved locoregional disease-free survival, distant disease-free survival, and breast cancer mortality, but not overall survival 4, 5

Surgical Considerations

  • For invasive tumors that are 1 cm or smaller in diameter and tumors of favorable histologic type, removal of level I nodes may be adequate 8
  • For staging purposes, removal of level I and level II nodes permits an accurate assessment of axillary nodal status 8

Clinical Implications

  • The presence of 4 or more positive lymph nodes places patients at substantially increased risk for locoregional recurrence of disease 1
  • Prophylactic chest wall irradiation in patients with 4 or more positive nodes substantially reduces the risk of local recurrence 1
  • Omitting regional nodal irradiation in patients with 4 or more positive nodes can lead to poor locoregional control and decreased survival 1, 2, 4

REFERENCES

1

breast cancer version 3.2014. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2014

2

breast cancer: noninvasive and special situations. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2010

3

invasive breast cancer version 1.2016, nccn clinical practice guidelines in oncology. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2016

4

nccn guidelines update: breast cancer. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2016

5

nccn guidelines update: breast cancer. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2016

6

nccn guidelines update: breast cancer. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2016

7

breast cancer version 3.2014. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2014